News Image

NASDAQ:SNY is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

By Mill Chart

Last update: Dec 28, 2023

Our stock screener has singled out SANOFI-ADR (NASDAQ:SNY) as a stellar value proposition. NASDAQ:SNY not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. We'll explore this further.

A Closer Look at Valuation for NASDAQ:SNY

ChartMill assigns a proprietary Valuation Rating to each stock. The score is computed by evaluating various valuation aspects, like price to earnings and free cash flow, both absolutely as relative to the market and industry. NASDAQ:SNY was assigned a score of 7 for valuation:

  • SNY is valuated reasonably with a Price/Earnings ratio of 10.61.
  • Based on the Price/Earnings ratio, SNY is valued cheaper than 89.11% of the companies in the same industry.
  • SNY is valuated cheaply when we compare the Price/Earnings ratio to 26.17, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 11.09, which indicates a very decent valuation of SNY.
  • Based on the Price/Forward Earnings ratio, SNY is valued cheaper than 89.11% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.06. SNY is valued slightly cheaper when compared to this.
  • SNY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SNY is cheaper than 95.05% of the companies in the same industry.
  • SNY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SNY is cheaper than 89.11% of the companies in the same industry.
  • SNY has an outstanding profitability rating, which may justify a higher PE ratio.

A Closer Look at Profitability for NASDAQ:SNY

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:SNY has achieved a 8:

  • The Return On Assets of SNY (10.12%) is better than 93.07% of its industry peers.
  • SNY has a Return On Equity of 17.47%. This is amongst the best in the industry. SNY outperforms 91.09% of its industry peers.
  • SNY's Return On Invested Capital of 15.53% is amongst the best of the industry. SNY outperforms 92.08% of its industry peers.
  • The last Return On Invested Capital (15.53%) for SNY is above the 3 year average (6.95%), which is a sign of increasing profitability.
  • SNY has a Profit Margin of 18.09%. This is amongst the best in the industry. SNY outperforms 93.07% of its industry peers.
  • SNY's Operating Margin of 27.75% is amongst the best of the industry. SNY outperforms 94.06% of its industry peers.
  • In the last couple of years the Operating Margin of SNY has grown nicely.
  • The Gross Margin of SNY (70.31%) is better than 78.22% of its industry peers.

A Closer Look at Health for NASDAQ:SNY

ChartMill assigns a proprietary Health Rating to each stock. The score is computed by evaluating various liquidity and solvency ratios and ranges from 0 to 10. NASDAQ:SNY was assigned a score of 7 for health:

  • An Altman-Z score of 3.14 indicates that SNY is not in any danger for bankruptcy at the moment.
  • SNY's Altman-Z score of 3.14 is fine compared to the rest of the industry. SNY outperforms 75.74% of its industry peers.
  • The Debt to FCF ratio of SNY is 2.59, which is a good value as it means it would take SNY, 2.59 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of SNY (2.59) is better than 90.59% of its industry peers.
  • A Debt/Equity ratio of 0.22 indicates that SNY is not too dependend on debt financing.
  • The current and quick ratio evaluation for SNY is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.

Growth Insights: NASDAQ:SNY

To evaluate a stock's growth potential, ChartMill utilizes a Growth Rating on a scale of 0 to 10. This comprehensive assessment considers various growth aspects, including historical and estimated EPS and revenue growth. NASDAQ:SNY has achieved a 4 out of 10:

  • The Earnings Per Share has grown by an nice 17.29% over the past year.
  • The Earnings Per Share has been growing by 8.29% on average over the past years. This is quite good.
  • The Revenue has grown by 11.47% in the past year. This is quite good.

More Decent Value stocks can be found in our Decent Value screener.

Check the latest full fundamental report of SNY for a complete fundamental analysis.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

SANOFI-ADR

NASDAQ:SNY (4/23/2024, 10:43:22 AM)

47.51

+0.36 (+0.76%)

SNY News

News Image12 days ago - InvestorPlaceThe $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today

Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.

News Image15 days ago - InvestorPlaceWhy Is Auddia (AUUD) Stock Up 192% Today?

Auddia stock is taking off on Monday with heavy trading of AUUD stock after the company received a new AI tech patent.

News Image15 days ago - InvestorPlaceAIRC Stock Alert: Blackstone Is Taking Apartment Income REIT Private

Apartment Income REIT stock is rising higher on Monday as investors in AIRC shares react to a deal to take the company private.

News Image15 days ago - InvestorPlaceSanofi Layoffs 2024: What to Know About the Latest SNY Job Cuts

Sanofi layoffs are coming for the company's R&D employees and it makes major changes to how it handles development going forward.

News Imagea month ago - Market News VideoFirst Week of May 17th Options Trading For Sanofi (SNY)
News Imagea month ago - Market News VideoFirst Week of September 20th Options Trading For Sanofi (SNY)
News Imagea month ago - InvestorPlaceTo the Moon and Beyond: 7 Stocks With Cosmic Potential

With the Fear and Greed Index at 69, it's an opportune to wager on these attractive Stocks with Moonshot Potential.

News Imagea month ago - InvestorPlacePassport to Profits: 7 Global Growth Gems to Diversify Your Holdings

With certain sectors in the domestic market appearing overstretched, these global growth stocks may offer better opportunities.

SNY Links
Follow us for more